$ME
-
Markets
23andme Navigates Chapter 11 Proceedings And Introduces New Genetic Health Report
$ME 23andMe Holding Co. (Nasdaq:ME), a well-known name in consumer genetics and biotechnology, has initiated voluntary Chapter 11 proceedings as…
Read More »